SIP sigma pharmaceuticals limited

aggressively marketing generics business , page-3

  1. 65 Posts.
    I think Hoopers experience in debt repackaging will be a bonus
    for Sigma and ultimately be the driver for the share-price. It's ridiculous statement by Aspen that tries to make a bigger deal out of debt than it really is.
    We are talking about 70 mil amount that is not even on the radar till next March.
    Opportunistic by all accounts.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.